Invesaro

Stocks BRSP Financial statements

Financial statements

BrightSpire Capital, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data BrightSpire Capital, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2018FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue158189501589291194365415359331
General and administrative15.412.726.631.926.650
Operating expenses0.67
Interest expense262147.187.76355.51121732723.7
Interest income0014312092.551.632.200
Pre-tax income94.5105-164-496-25132.849.2-23.6-134-60.3
Income tax1.522.2137.13.17-10.96.282.441.061.06-21.5
Net income76.188.5-168-415-353-10145.8-15.5-132-31.1
EPS, basic1.601.86-1.41-3.25-2.75-0.790.35-0.12-1.05-0.26
EPS, diluted1.601.86-1.41-3.25-2.75-0.790.34-0.12-1.05-0.26
Shares, basic (weighted)44.444.4121128129128127127127127
Shares, diluted (weighted)44.444.4121128129128129127127127
Dividend per share1.601.650.300.580.790.800.720.64

Balance sheet

FY2016FY2018FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents1425.277.369.647526030625830266.8
Lease right-of-use assets025.522.12525.222.123.219.8
Total assets1,8398,6617,4146,2125,6384,7504,1983,7233,565
Total liabilities4325,8165,2134,2534,1473,3612,9202,6782,636
Total debt3902,6203,1882,3933,1673,1642,7162,4912,469
Paid-in capital8212,8992,9092,8442,8562,8542,8652,8652,863
Retained earnings259-193-820-1,234-1,411-1,467-1,586-1,812-1,926
Other comprehensive income0-0.428.354.68.79-0.68-2.56-6.340
Shareholders' equity1,0802,7072,1191,6661,4551,3881,2771,048938
Total equity1,2361,4082,8452,2011,9591,4911,3891,2781,046928
Total liabilities and equity1,8398,6617,4146,2125,6384,7504,1983,7233,565
Shares outstanding129

Cash flow statement

FY2016FY2018FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income109128-177-463-376-10546.8-15.6-136-38.8
Depreciation and amortization0.159.149110359.836.434.133.540.536.3
Stock-based compensation007.1110.84.37147.8914.111.612.8
Deferred income tax01.7428.4-4.65-0.17-0.09-2.05-1.04-1.13-22.3
Change in receivables0011.1-9.1413.2-1.2-3.071.514.53-5.52
Cash from operations88.510710113796.4-21.312513810373
Capital expenditures-0.07-0.31-415-24.2-23.2-9.92-3.97-7.06-6.09-17.9
Acquisitions-729-127
Purchases of investments0-58.700
Sales and maturities of investments0015010.200
Cash from investing199439-468-4161,003-55689.3384313-420
Stock issued00.020
Share buybacks00-18.30-6.59-10.9
Dividends paid00-185-218-51.7-51.9-99.4-104-99.1-83
Cash from financing-320-552488287-754384-161-559-32868.9
Exchange rate effect00-0.180.29-0.69-0.76-0.90.080.071.12
Net change in cash-31.8-5.411208.22344-19352.3-36.788.6-277
Free cash flow88.4107-31411373.1-31.212113197.355.1
Interest paid20.122.981.714311276.3126190174146
Income taxes paid1.2910.521.2-3.09-5.964.830.60.272.04-1.87

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $4.09 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Net margin-8.0%Net income / revenue.
FCF margin22.0%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin25.4%Cash from operations / revenue.
Return on equity (ROE)-3.1%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)-0.7%Net income / average total assets.
Stock-based pay / revenue3.6%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue3.5%Capital expenditures / revenue.
D&A / revenue9.5%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-7.9%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-3.2%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y2.6%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-29.4%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-16.5%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-5.4%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-43.4%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-23.1%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y-5.5%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y-11.1%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y-6.8%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y16.4%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-10.5%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y-12.2%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y-10.8%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y-4.3%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-9.1%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y-10.5%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-0.4%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-0.6%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-0.3%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Debt / equity3.18xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets73.3%Total debt / total assets.
Liabilities / assets77.3%Total liabilities / total assets.
Net debt$2.68BTotal debt - cash - short-term investments. Negative means more cash than debt.
Tangible book value$863.0MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.09xRevenue / average total assets.
Capex / operating cash flow13.7%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.21Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$2.65Revenue / diluted weighted shares.
FCF per share$0.58Free cash flow / diluted weighted shares.
Operating cash flow per share$0.67Cash from operations / diluted weighted shares.
Book value per share$6.81Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$6.81Tangible book value / shares outstanding.
Cash per share$0.54(Cash + short-term investments) / shares outstanding.
Dividends / FCF114.1%Dividends paid / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$517.5MShare price x shares outstanding.
Enterprise value$3.20BMarket cap + total debt - cash - short-term investments.
P/S1.54xMarket cap / revenue.
P/B0.60xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book0.60xMarket cap / tangible book value, when positive.
P/FCF7.02xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF6.06xMarket cap / cash from operations, when positive.
EV/Sales9.51xEnterprise value / revenue.
EV/FCF43.3xEnterprise value / free cash flow, when both are positive.
FCF yield14.3%Free cash flow / market cap.
Earnings yield-5.2%Net income / market cap (the inverse of P/E).
Dividend yield16.3%Dividends paid over the period / market cap.
Shareholder yield16.3%(Dividends paid + share buybacks) / market cap.
What was BrightSpire Capital, Inc.'s revenue in fiscal 2025?

BrightSpire Capital, Inc. reported revenue of $330.6M for fiscal 2025, 7.9% lower than the year before.

Was BrightSpire Capital, Inc. profitable in fiscal 2025?

No. It reported a net loss of $31.1M.

How much free cash flow did BrightSpire Capital, Inc. generate in fiscal 2025?

Cash from operations of $73.0M minus capital expenditures of $17.9M left free cash flow of $55.1M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to BrightSpire Capital, Inc.